Showing results (111-120 of 322) with videos related to

Sort By:
Pageof 33
Frontiers in Genetics|October 28, 2021
hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 Mutation in MiceFabrizio Martelli, Paola Verachi, Maria Zingariello, et al.
Leukemia Research|January 1, 2014
Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paperGiovanni Barosi, Alessandro M Vannucchi, Valerio De Stefano, et al.
Nature Reviews. Disease Primers|April 17, 2025
Polycythaemia veraClaire N Harrison, Tiziano Barbui, Prithviraj Bose, et al.
Cancer Research|September 26, 2015
Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary MyelofibrosisChristophe Martinaud, Christophe Desterke, Johanna Konopacki, et al.
Biochimica Et Biophysica Acta|April 2, 2003
Redox modulation of protein kinase/phosphatase balance in melanoma cells: the role of endogenous and gamma-glutamyltransferase-dependent H2O2 productionLisa Pieri, Silvia Dominici, Barbara Del Bello, et al.
Tumori|November 11, 2003
Redox modulation of NF-kappaB nuclear translocation and DNA binding in metastatic melanoma. The role of endogenous and gamma-glutamyl transferase-dependent oxidative stressSilvia Dominici, Athanase Visvikis, Lisa Pieri, et al.
Oncotarget|December 13, 2017
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/CIP2A axisNiccolò Bartalucci, Laura Calabresi, Manjola Balliu, et al.
Future Oncology (London, England)|January 18, 2023
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasmsFrancesco Mannelli, Paola Guglielmelli, Paola Fazi, et al.
Leukemia Research|February 15, 2017
Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapySrdan Verstovsek, Claire N Harrison, Jean-Jacques Kiladjian, et al.
Blood|May 19, 2010
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteriaAlessandra Carobbio, Guido Finazzi, Elisabetta Antonioli, et al.
Pageof 33